Prime Medicine, Inc. Quarterly Debt-to-equity in % from Q2 2023 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Prime Medicine, Inc. quarterly Debt-to-equity history and growth rate from Q2 2023 to Q4 2024.
Prime Medicine, Inc. Debt-to-equity for the quarter ending December 31, 2024 was 53.4 %, a 145% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	53.4	+31.6	+145%	Dec 31, 2024
Q3 2024	43.9	+27.5	+169%	Sep 30, 2024
Q2 2024	30.9	+3.8	+14.1%	Jun 30, 2024
Q1 2024	26.4			Mar 31, 2024
Q4 2023	21.9			Dec 31, 2023
Q3 2023	16.3			Sep 30, 2023
Q2 2023	27			Jun 30, 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.